12 results on '"Makino, Hirofumi"'
Search Results
2. Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.
- Author
-
Tsukamoto, Naoko, Otsuka, Fumio, Ogura-Ochi, Kanako, Inagaki, Kenichi, Nakamura, Eri, Toma, Kishio, Terasaka, Tomohiro, Iwasaki, Yasumasa, and Makino, Hirofumi
- Subjects
- *
MELATONIN , *ADRENOCORTICOTROPIC hormone , *BONE morphogenetic proteins , *GENETIC regulation , *PITUITARY gland , *NEURAL stimulation - Abstract
Highlights: [•] Melatonin receptor (MTR) activation suppresses CRH-induced ACTH synthesis by AtT20 cells. [•] BMP-4 upregulates MT1R, while BMP-4 enhances the MTR action on ACTH production. [•] MTR stimulation enhances BMP-Smad1/5/8 signaling via activating AKT pathway. [•] MTR and BMP-4 actions are mutually augmented, leading to fine-tuning of ACTH production. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
3. Regulatory role of kit ligand–c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells
- Author
-
Miyoshi, Tomoko, Otsuka, Fumio, Nakamura, Eri, Inagaki, Kenichi, Ogura-Ochi, Kanako, Tsukamoto, Naoko, Takeda, Masaya, and Makino, Hirofumi
- Subjects
- *
OVUM , *LABORATORY rats , *BONE morphogenetic proteins , *DIETHYLSTILBESTROL , *FIBROBLAST growth factors , *FORSKOLIN , *STEROIDOGENIC acute regulatory protein , *ACTIVIN receptor-like kinase 1 - Abstract
Abstract: Although kit ligand (KL)–c-kit interaction is known to be critical for oogenesis and folliculogenesis, its role in ovarian steroidogenesis has yet to be elucidated. We studied the impact of KL–c-kit interaction in regulation of steroidogenesis using rat oocyte/granulosa cell co-culture. In the presence of oocytes, soluble KL suppressed FSH-induced estradiol production and aromatase mRNA expression without affecting FSH-induced progesterone production. The KL effect on steroidogenesis was interrupted by an anti-c-kit neutralizing antibody, suggesting that KL–c-kit interaction is involved in suppression of estrogen by granulosa cells through oocyte c-kit action. The cAMP-PKA pathway activity was not directly involved in the estrogen regulation by KL–c-kit action. It was of note that KL treatment increased the expression levels of oocyte-derived FGF-8, GDF-9 and BMP-6, while it reduced the expression levels of oocyte-derived BMP-15 in the oocyte-granulosa cell co-culture. Given the findings that FGF-8, but not GDF-9, BMP-6 or -15, suppressed FSH-induced estrogen production by granulosa cells, oocyte-derived FGF-8 is linked to suppression of FSH-induced estrogen production through the KL–c-kit interaction. Furthermore, the suppression of FSH-induced estrogen production by KL in the co-culture was reversed by a FGF receptor kinase inhibitor and the effect of the inhibitor was enhanced in combination with extracellular-domain protein of BMPRII, which interferes with BMP-15 and GDF-9 activities. Thus, the actions of endogenous oocyte factors including FGF-8 and BMP-15/GDF-9 were involved in the KL activity that inhibited FSH-induced estradiol production. Collectively, the results indicate that KL–c-kit interaction plays a role in estrogenic regulation through oocyte-granulosa cell communication. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
4. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling
- Author
-
Matsumoto, Yoshinori, Otsuka, Fumio, Hino, Jun, Miyoshi, Tomoko, Takano, Mariko, Miyazato, Mikiya, Makino, Hirofumi, and Kangawa, Kenji
- Subjects
- *
BONE morphogenetic proteins , *CELL differentiation , *BONE cells , *CELLULAR signal transduction , *EMBRYOLOGY , *LABORATORY mice , *SMAD proteins - Abstract
Abstract: Despite the involvement of BMP-3b (also called GDF-10) in osteogenesis, embryogenesis and adipogenesis, the functional receptors and intracellular signaling of BMP-3b have yet to be elucidated. In the present study, we investigated the cellular mechanism of BMP-3b in osteoblast differentiation using mouse myoblastic C2C12 cells. BMP-3b stimulated activin/TGF-β-responsive promoter activities. The stimulatory actions of BMP-3b on activin/TGF-β-responsive activities were suppressed by co-treatment with BMP-2. BMP-responsive promoter activities stimulated by BMP-2 were significantly inhibited by treatment with BMP-3b. BMP-3b suppressed the expression of osteoblastic markers including Runx2, osteocalcin and type-1 collagen induced by BMP-2, -4, -6 and -7. BMP-2-induced Smad1/5/8 phosphorylation and mRNA levels of the BMP target gene Id-1 were suppressed by co-treatment with BMP-3b, although BMP-3b failed to activate Smad1/5/8 signaling. Of interest, the BMP-3b suppression of BMP-2-induced Id-1 expression was not observed in cells overexpressing Smad4 molecules. On the other hand, BMP-3b directly activated Smad2/3 phosphorylation and activin/TGF-β target gene PAI-1 mRNA expression, while BMP-2 suppressed BMP-3b-induced Smad2/3 signal activation. BMP-2 inhibition of BMP-3b-induced PAI-1 expression was also reversed by overexpression of Smad4. Analysis using inhibitors for BMP–Smad1/5/8 pathways revealed that these BMP-3b effects were mediated via receptors other than ALK-2, -3 and -6. Furthermore, results of inhibitory studies using extracellular domains for BMP receptor constructs showed that the activity of BMP-3b was functionally facilitated by a combination of ALK-4 and ActRIIA. Collectively, BMP-3b plays an inhibitory role in the process of osteoblast differentiation, in which BMP-3b and BMP-2 are mutually antagonistic possibly by competing with the availability of Smad4. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
5. BMP action in the pituitary: Its possible role in modulating somatostatin sensitivity in pituitary tumor cells
- Author
-
Otsuka, Fumio, Tsukamoto, Naoko, Miyoshi, Tomoko, Iwasaki, Yasumasa, and Makino, Hirofumi
- Subjects
- *
BONE morphogenetic proteins , *PITUITARY tumors , *SOMATOSTATIN receptors , *CANCER cell growth regulation , *DOPAMINE agonists , *PROOPIOMELANOCORTIN - Abstract
Abstract: The existence of a functional bone morphogenetic protein (BMP) system in the pituitary has been recognized. Recent studies have provided evidence that BMPs elicit differential actions in the regulation of prolactin (PRL) and adrenocorticotropin (ACTH) release in lactotropinoma and corticotropinoma cells, respectively. BMPs play a key role in the modulation of somatostatin receptor (SSTR) sensitivity of lactosomatotrope cells in an autocrine/paracrine manner. In addition, SSTR action enhances BMP responsiveness in corticotrope cells. The functional link between BMP receptor signaling and SSTR actions may be crucial for individual tolerance to somatostatin analogs for controlling PRL and ACTH production. Adjustment of the endogenous SSTR sensitivity may be an effective strategy to inhibit the growth activity and hormonal productivity of intractable pituitary tumors. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
6. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α
- Author
-
Takano, Mariko, Otsuka, Fumio, Matsumoto, Yoshinori, Inagaki, Kenichi, Takeda, Masaya, Nakamura, Eri, Tsukamoto, Naoko, Miyoshi, Tomoko, Sada, Ken-ei, and Makino, Hirofumi
- Subjects
- *
PEROXISOMES , *CELL proliferation , *BONE morphogenetic proteins , *TUMOR necrosis factors , *THIAZOLIDINEDIONES , *DRUG side effects , *BONE growth , *GENE expression - Abstract
Abstract: Recent studies have suggested possible adverse effects of thiazolidinediones on bone metabolism. However, the detailed mechanism by which the activity of PPAR affects bone formation has not been elucidated. Impaired osteoblastic function due to cytokines is critical for the progression of inflammatory bone diseases. In the present study, we investigated the cellular mechanism by which PPAR actions interact with osteoblast differentiation regulated by BMP and TNF-α using mouse myoblastic C2C12 cells. BMP-2 and -4 potently induced the expression of various bone differentiation markers including Runx2, osteocalcin, type-1 collagen and alkaline phosphatase (ALP) in C2C12 cells. When administered in combination with a PPARα agonist (fenofibric acid) but not with a PPARγ agonist (pioglitazone), BMP-4 enhanced osteoblast differentiation through the activity of PPARα. The osteoblastic changes induced by BMP-4 were readily suppressed by treatment with TNF-α. Interestingly, the activities of PPARα and PPARγ agonists reversed the suppression by TNF-α of osteoblast differentiation induced by BMP-4. Furthermore, TNF-α-induced phosphorylation of MAPKs, NFκB, IκB and Stat pathways was inhibited in the presence of PPARα and PPARγ agonists with reducing TNF-α receptor expression. In view of the finding that inhibition of SAPK/JNK, Stat and NFκB pathways reversed the TNF-α suppression of osteoblast differentiation, we conclude that these cascades are functionally involved in the actions of PPARs that antagonize TNF-α-induced suppression of osteoblast differentiation. It was further discovered that the PPARα agonist enhanced BMP-4-induced Smad1/5/8 signaling through downregulation of inhibitory Smad6/7 expression, whereas the PPARγ agonist impaired this activity by suppressing BMPRII expression. On the other hand, BMPs increased the expression levels of PPARα and PPARγ in the process of osteoblast differentiation. Thus, PPARα actions promote BMP-induced osteoblast differentiation, while both activities of PPARα and PPARγ suppress TNF-α actions. Collectively, our present data establishes that PPAR activities are functionally involved in modulating the interaction between the BMP system and TNF-α receptor signaling that is crucial for bone metabolism. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
7. Interaction between gonadotropin-releasing hormone and bone morphogenetic protein-6 and -7 signaling in LβT2 gonadotrope cells
- Author
-
Takeda, Masaya, Otsuka, Fumio, Takahashi, Hiroaki, Inagaki, Kenichi, Miyoshi, Tomoko, Tsukamoto, Naoko, Makino, Hirofumi, and Lawson, Mark A.
- Subjects
- *
GONADOTROPIN releasing hormone , *BONE morphogenetic proteins , *CELLULAR signal transduction , *GENETIC transcription regulation , *ESTROGEN receptors , *TRANSFORMING growth factors-beta , *FOLLICLE-stimulating hormone , *LABORATORY mice - Abstract
Abstract: It is known that bone morphogenetic proteins (BMPs) regulate gonadotropin transcription and production by pituitary gonadotrope cells. However, the role of BMPs in gonadotropin-releasing hormone (GnRH)-induced FSH production remains uncertain. Here, we describe a functional link between BMP-6 and BMP-7 signals and FSH transcriptional activity induced by GnRH using mouse gonadotrope LβT2 cells. In LβT2 cells, BMP-6 and BMP-7 increased mouse FSHβ-promoter activity in a concentration-dependent manner. The induction by BMP-6 and BMP-7 was inhibited by treatment with extracellular domains of ActRII but not BMPRII. These findings suggest that the type II receptor ActRII participates in BMP-induced FSHβ transcription regulation. Notably, BMP-6, but not BMP-7, enhanced GnRH-induced FSHβ-promoter activity in LβT2 cells. Since GnRH stimulated MAPK phosphorylation in LβT2 cells, a functional link between MAPK and FSHβ transcription was examined. Inhibition of the ERK pathway, but not that of p38 or SAPK/JNK signaling, suppressed GnRH-induced FSHβ transcription, suggesting that ERK is functionally involved in GnRH-induced FSHβ transcription. Co-treatment with BMP-7, but not with BMP-6, suppressed GnRH-induced MAPK phosphorylation in LβT2 cells. Thus, the difference between BMP-6 and BMP-7 in enhancing GnRH-induced FSHβ transcription may be due to the differential effects of BMP ligands on GnRH-induced ERK signaling. On the other hand, GnRH reduced Smad1/5/8 phosphorylation but increased Smad6/7 expression. These findings imply the presence of a functional link between GnRH action, MAPK signaling and the BMP system in pituitary gonadotropes for fine-tuning of FSH gene expression. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
8. Functional interaction of bone morphogenetic protein and growth hormone releasing peptide in adrenocorticotropin regulation by corticotrope cells
- Author
-
Tsukamoto, Naoko, Otsuka, Fumio, Miyoshi, Tomoko, Inagaki, Kenichi, Nakamura, Eri, Terasaka, Tomohiro, Takeda, Masaya, Ogura, Toshio, Iwasaki, Yasumasa, and Makino, Hirofumi
- Subjects
- *
BONE morphogenetic proteins , *GROWTH hormone releasing factor , *ADRENOCORTICOTROPIC hormone , *MITOGEN-activated protein kinases , *PROTEIN kinases , *VASOPRESSIN , *PROOPIOMELANOCORTIN , *TRANSFORMING growth factors , *PHYSIOLOGICAL control systems - Abstract
Abstract: Mechanisms by which GHRP stimulates ACTH release in corticotrope cells were investigated using mouse corticotrope AtT20 cells by focusing on the biological activity of BMP-4. GHRP-2 increased ACTH and cAMP secretion by AtT20 cells; however, its effects were less potent than the effects of CRH. BMP-4 suppressed basal ACTH production and POMC transcription, and the inhibition of endogenous BMP receptor signaling led to an increase in ACTH production. Of note, BMP-4 suppressed ACTH production and POMC-promoter activity induced by CRH more efficaciously than that induced by GHRP-2. BMP-4 had no significant effect on cAMP synthesis induced by CRH or GHRP-2. Stimulation with CRH, but not GHRP-2, activated ERK1/2, p38, SAPK/JNK and Akt phosphorylation, in which CRH-induced phosphorylation of ERK and p38 was suppressed by BMP-4. GHRP-2-induced ACTH secretion was not affected by inhibitors of ERK, p38 and Akt pathways, which effectively suppressed CRH-induced ACTH release. Blockage of the cAMP-PKA pathway reversed CRH- as well as GHRP-2-induced ACTH secretion. Furthermore, the inhibition of ERK and p38 significantly reduced cAMP synthesis induced by CRH but not by GHRP-2. Thus, CRH activates ACTH production through ERK and p38 pathways in addition to the cAMP-PKA pathway, which is also activated downstream of MAPK. On the other hand, GHRP-2-induced ACTH production was predominantly linked to the cAMP-PKA pathway. Moreover, CRH and GHRP-2 upregulated BMP receptor signaling, while BMP-4, CRH and GHRP-2 had no significant effect on the expression level of GHSR. In addition, GHRP-2 suppressed the expression of Smad7, which is an inhibitor of the BMP-Smad1/5/8 pathway. Collectively, the results revealed a functional interaction between GHRP-2 and BMP signaling, in which endogenous BMP may act as an autoregulatory system in controlling ACTH production. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
9. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation
- Author
-
Masuda, Hiroko, Otsuka, Fumio, Matsumoto, Yoshinori, Takano, Mariko, Miyoshi, Tomoko, Inagaki, Kenichi, Shien, Tadahiko, Taira, Naruto, Makino, Hirofumi, and Doihara, Hiroyoshi
- Subjects
- *
FIBROBLAST growth factors , *BONE morphogenetic proteins , *ESTROGEN receptors , *BREAST cancer , *CANCER cells , *CELL proliferation , *MITOGEN-activated protein kinases , *AROMATASE , *PHOSPHORYLATION - Abstract
Abstract: Estrogen is involved in the development and progression of breast cancer. Here we investigated the effect of fibroblast growth factor (FGF)-8 on breast cancer cell proliferation caused by estrogen using human breast cancer MCF-7 cells. MCF-7 cells express estrogen receptor (ER)α, ERβ, FGF receptors, and Smad signaling molecules. Estradiol stimulated MCF-7 cell proliferation in a concentration-responsive manner, whereas BSA-bound estradiol had a weak effect on MCF-7 cell mitosis compared with the effect of free estradiol. It is notable that estrogen-induced cell proliferation was enhanced in the presence of FGF-8 and that the combined effects were reversed in the presence of an FGF-receptor kinase inhibitor or an ER antagonist. It was also revealed that FGF-8 increased the expression levels of ERα, ERβ and aromatase mRNAs, while estradiol reduced the expression levels of ERs, aromatase and steroid sulfatase in MCF-7 cells. FGF-8-induced phosphorylation of FGF receptors was augmented by estradiol, which was reversed by an ER antagonist. FGF-8-induced activation of MAPKs and AKT signaling was also upregulated in the presence of estrogen. On the other hand, FGF-8 suppressed BMP-7 actions that are linked to mitotic inhibition by activating the cell cycle regulator cdc2. FGF-8 was revealed to inhibit BMP receptor actions including Id-1 promoter activity and Smad1/5/8 phosphorylation by suppressing expression of BMP type-II receptors and by increasing expression of inhibitory Smads. Collectively, the results indicate that FGF-8 acts to facilitate cell proliferation by upregulating endogenous estrogenic actions as well as by suppressing BMP receptor signaling in ER-expressing breast cancer cells. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
10. Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells
- Author
-
Tsukamoto, Naoko, Otsuka, Fumio, Miyoshi, Tomoko, Inagaki, Kenichi, Nakamura, Eri, Suzuki, Jiro, Ogura, Toshio, Iwasaki, Yasumasa, and Makino, Hirofumi
- Subjects
- *
BONE morphogenetic proteins , *PROLACTIN , *GENETIC regulation , *SOMATOSTATIN , *BROMOCRIPTINE , *DOPAMINE agonists , *MESSENGER RNA - Abstract
Abstract: Involvement of the pituitary BMP system in the modulation of prolactin (PRL) secretion regulated by somatostatin analogs, including octreotide (OCT) and pasireotide (SOM230), and a dopamine agonist, bromocriptine (BRC), was examined in GH3 cells. GH3 cells are rat pituitary somato-lactotrope tumor cells that express somatostatin receptors (SSTRs) and BMP system molecules including BMP-4 and -6. Treatment with BMP-4 and -6 increased PRL and cAMP secretion by GH3 cells. The BMP-4 effects were neutralized by adding a BMP-binding protein Noggin. These findings suggest the activity of endogenous BMPs in augmenting PRL secretion by GH3 cells. BRC and SOM230 reduced PRL secretion, but OCT failed to reduce the PRL level. In GH3 cells activated by forskolin, BRC suppressed forskolin-induced PRL secretion with reduction in cAMP levels. OCT did not affect forskolin-induced PRL level, while SOM230 reduced PRL secretion and PRL mRNA expression induced by forskolin. BMP-4 treatment enhanced the reducing effect of SOM230 on forskolin-induced PRL level while BMP-4 did not affect the effects of OCT or BRC. Noggin treatment had no significant effect on the BRC actions reducing PRL levels by GH3 cells. However, in the presence of Noggin, OCT elicited an inhibitory effect on forskolin-induced PRL secretion and PRL mRNA expression, whereas the SOM230 effect on PRL reduction was in turn impaired. It was further found that BMP-4 and -6 suppressed SSTR-2 but increased SSTR-5 mRNA expression of GH3 cells. These findings indicate that Noggin rescues SSTR-2 but downregulates SSTR-5 by neutralizing endogenous BMP actions, leading to an increase in OCT sensitivity and a decrease in SOM230 sensitivity of GH3 cells. In addition, BMP signaling was facilitated in GH3 cells treated with forskolin. Collectively, these findings suggest that BMPs elicit differential actions in the regulation of PRL release dependent on cellular cAMP-PKA activity. BMPs may play a key role in the modulation of SSTR sensitivity of somato-lactotrope cells in an autocrine/paracrine manner. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
11. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-α in C2C12 cells
- Author
-
Matsumoto, Yoshinori, Otsuka, Fumio, Takano, Mariko, Mukai, Tomoyuki, Yamanaka, Ryutaro, Takeda, Masaya, Miyoshi, Tomoko, Inagaki, Kenichi, Sada, Ken-ei, and Makino, Hirofumi
- Subjects
- *
GLUCOCORTICOID receptors , *OSTEOCLASTS , *CELL differentiation , *BONE morphogenetic proteins , *TUMOR necrosis factors , *RHEUMATOID arthritis , *CELLULAR mechanics , *ESTROGEN receptors - Abstract
Abstract: Imbalanced functions between osteoclasts and osteoblasts are involved in inflammatory bone damage. The clinical effectiveness of blocking TNF-α in treatment of active rheumatoid arthritis established the significance of TNF-α in the pathogenesis. In the present study, we investigated the cellular mechanism by which estrogen and glucocorticoid interact in osteoblastic differentiation regulated by BMP and TNF-α using mouse myoblastic C2C12 cells. The expression of estrogen receptors, (ER)α and ERβ, and glucocorticoid receptor (GCR) was significantly increased by BMP-2 treatment regardless of the presence of estradiol and dexamethasone. Estradiol, but not dexamethasone, enhanced BMP-induced Runx2 and osteocalcin expression in C2C12 cells. In addition, TNF-α suppressed BMP-2-induced Runx2 and osteocalcin expression, and estradiol and dexamethasone reversed the TNF-α effects on BMP-2-induced Runx2 expression. Dexamethasone also abolished osteocalcin expression induced by BMP-2. Interestingly, BMP-2-induced Smad1/5/8 phosphorylation and Id-1 promoter activity were enhanced by estradiol pretreatment. On the other hand, dexamethasone suppressed BMP-2-induced Smad1/5/8 activation. TNF-α-induced SAPK/JNK activity was suppressed by estradiol, while NFκB phosphorylation was inhibited by dexamethasone. Of note, the inhibitory effects of TNF-α on BMP-2-induced Runx2 and osteocalcin expression were reversed by SAPK/JNK inhibition regardless of the presence of estradiol. The estradiol effects that enhance BMP-2-induced Runx2 and osteocalcin mRNA expression were restored by antagonizing ER, and moreover, membrane-impermeable estradiol-BSA failed to enhance the BMP-2-induced osteoblastic differentiation. Thus, estrogen and glucocorticoid are functionally involved in the process of osteoblast differentiation regulated by BMPs and TNF-α. BMP-2 increases the sensitivities of ERs and GCR, whereas estrogen and glucocorticoid differentially regulate BMP-Smad and TNF-α signaling. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
12. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells
- Author
-
Miyoshi, Tomoko, Otsuka, Fumio, Yamashita, Misuzu, Inagaki, Kenichi, Nakamura, Eri, Tsukamoto, Naoko, Takeda, Masaya, Suzuki, Jiro, and Makino, Hirofumi
- Subjects
- *
FIBROBLAST growth factors , *BONE morphogenetic proteins , *STEROIDS , *SOMATIC cells , *LABORATORY rats , *MOLECULAR biology , *PROGESTERONE , *MITOGEN-activated protein kinases - Abstract
Abstract: Bone morphogenetic proteins (BMPs) have been recognized as crucial molecules in regulating ovarian physiology, with different BMPs having differential actions in FSH-induced estradiol production. To identify the roles of oocyte factors that modulate steroidogenesis controlled by BMPs, we here investigated the effects of FGF-8 in rat granulosa/oocyte co-cultures. FGF-8 potently suppressed FSH-induced estradiol production, but did not affect cAMP-induced estradiol produced by rat granulosa cells. FGF-8 had no effects on progesterone and cAMP production induced by FSH and forskolin. The inhibitory effects of FGF-8 on FSH-induced estradiol production were not altered by BMP-2, -4, -6 or -7. In the presence of FGF-8, BMPs suppressed FSH-induced progesterone by reducing cAMP, suggesting that FGF-8 and BMP independently regulate FSH receptor signaling. Notably, FGF-8-induced ERK and SAPK/JNK phosphorylation in granulosa cells, in which ERK activation was further enhanced by FSH and oocytes. Inhibition of ERK and SAPK/JNK reduced FSH-induced progesterone and cAMP levels, suggesting that the activation of these pathways enhances FSH-induced cAMP signaling. In addition, ERK inhibition upregulated FSH-induced estradiol synthesis, indicating that ERK pathway is also involved in suppressing aromatase activity in granulosa cells. Interestingly, FGF-8 enhanced BMP-induced Smad1/5/8 and Id-1-promoter activities with decreased expression of Smad6/7. Since the SAPK/JNK inhibitor inhibited FGF-8 effects in upregulating Id-1 transcription, SAPK/JNK appears to be involved in the mechanism by which FGF-8 enhances BMP–Smad signaling. Furthermore, in the presence of oocytes, the inhibition of endogenous FGF receptor signaling suppressed FSH- and forskolin-induced progesterone and cAMP, showing that endogenous FGF system is involved in activation of FSH-induced cAMP–PKA signaling via ERK and SAPK/JNK. Thus, the oocyte factor, FGF-8, not only suppresses FSH-induced estradiol production by activating ERK, but also enhances BMP–Smad signaling in granulosa cells. This interaction between FGF-8 and BMPs may play a key role in regulating steroidogenesis through oocyte-granulosa cell communication. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.